The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 6, Pages e99391
Publisher
Public Library of Science (PLoS)
Online
2014-06-10
DOI
10.1371/journal.pone.0099391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation
- (2015) Erik A. Nelson et al. Oncotarget
- The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway
- (2014) Sophia Pinz et al. PLoS One
- Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs
- (2013) Byung-Hak Kim et al. BIOCHEMICAL PHARMACOLOGY
- JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
- (2013) W. Warsch et al. BLOOD
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- A new player in Pol II pausing
- (2013) Nicholas J Fuda et al. EMBO JOURNAL
- A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
- (2013) F Hayakawa et al. Blood Cancer Journal
- Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F
- (2013) L Ma et al. Blood Cancer Journal
- Immediate-early gene activation by the MAPK pathways: what do and don't we know?
- (2012) Amanda O'Donnell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function
- (2012) Jian-Xin Lin et al. IMMUNITY
- Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
- (2012) Emily J. Hanan et al. JOURNAL OF MEDICINAL CHEMISTRY
- SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation
- (2012) Thang Van Nguyen et al. MOLECULAR CELL
- Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans
- (2012) Karen Adelman et al. NATURE REVIEWS GENETICS
- Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera
- (2012) Manfred Kraus et al. PLoS One
- Defining the Status of RNA Polymerase at Promoters
- (2012) Leighton J. Core et al. Cell Reports
- Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications
- (2011) Young-Sam Keum Annals of the New York Academy of Sciences
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2
- (2011) Malay Mandal et al. NATURE IMMUNOLOGY
- Two Naturally Occurring Terpenes, Dehydrocostuslactone and Costunolide, Decrease Intracellular GSH Content and Inhibit STAT3 Activation
- (2011) Elena Butturini et al. PLoS One
- JAK2 inhibitors: What's the true therapeutic potential?
- (2010) Fabio P.S. Santos et al. BLOOD REVIEWS
- Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
- (2010) Stephanos Ioannidis et al. JOURNAL OF MEDICINAL CHEMISTRY
- AZ960, a Novel Jak2 Inhibitor, Induces Growth Arrest and Apoptosis in Adult T-Cell Leukemia Cells
- (2010) J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Acetylation modulates prolactin receptor dimerization
- (2010) L. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Electrophilic tuning of the chemoprotective natural product sulforaphane
- (2010) Y.-H. Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
- (2009) Emily Ho et al. JOURNAL OF NUTRITION
- A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization
- (2008) Judith Müller et al. ANALYTICAL BIOCHEMISTRY
- Multi-targeted prevention of cancer by sulforaphane
- (2008) John D. Clarke et al. CANCER LETTERS
- Discovery of Chromone-Based Inhibitors of the Transcription Factor STAT5
- (2008) Judith Müller et al. CHEMBIOCHEM
- S-Glutathionylation Impairs Signal Transducer and Activator of Transcription 3 Activation and Signaling
- (2008) Yi Xie et al. ENDOCRINOLOGY
- The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes
- (2008) Anne Rascle et al. EXPERIMENTAL CELL RESEARCH
- In vivo identification of novel STAT5 target genes
- (2008) B. Basham et al. NUCLEIC ACIDS RESEARCH
- Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells
- (2008) Suvarna Bhamre et al. PROSTATE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started